1. Cho KW, Lee SY, Kim SJ. Treatment of congenital nasolacrimal duct obstruction using silicone intubation set. J Korean Ophthalmol Soc. 1995; 36:553–8.
2. Kushner BJ. Congenital nasolacrimal system obstruction. Arch Ophthalmol. 1982; 100:597–600.
Article
3. Nelson LR, Calhoun JH, Menduke H. Medical management of congenital nasolacrimal duct obstruction. Ophthalmology. 1985; 92:1187–90.
Article
4. Baker JD. Treatment of congenital nasolacrimal system obstruction. J Pediatr Ophthalmol Strabismus. 1985; 22:34–6.
Article
5. Usha K, Smitha S, Shah N, et al. Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction. J AAPOS. 2006; 10:469–72.
Article
6. Lee JJ, Ahn JH, Kim JL, Yang JW. The clinical outcome of endoscopic silicone tube intubation for congenital nasolacrimal duct obstruction. J Korean Ophthalmol Soc. 2012; 7:929–33.
Article
7. Vanderveen DK, Jones DT, Tan H, Petersen RA. Endoscopic dacryocystorhinostomy in children. J AAPOS. 2001; 5:143–7.
Article
8. Shin HM, Lew H, Yun YS. Fungus at removed silicone tubes in nasolacrimal duct obstruction patients. J Korean Ophthalmol Soc. 2004; 12:1967–72.
9. Kuchar A, Lukas J, Steinkogler FJ. Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction. Acta Ophthalmol Scand. 2000; 78:694–8.
Article
10. Ruby AJ, Lissner GS, O'Grady R. Surface reaction on silicone tubes used in the treatment of nasolacrimal drainage system obstruction. Ophthalmic Sur. 1991; 22:745–8.
Article
11. Shin HM, Lew HL, Lee JM. Cytologic study of removed silicone tube in nasolacrimal duct obstruction patients with the liquid-based thin layer preparation techinique. J Korean Ophthalmol Soc. 2004; 45:707–13.
12. Kodsi S. Community-acquired methicillin-resistant Staphylococcus aureus in association with chronic dacryocystitis secondary to congenital nasolacrimal duct obstruction. J AAPOS. 2006; 10:583–4.
Article